Document Detail

In vitro effect of dextran-benzene-tetra-carboxylate hemoglobin on human blood rheological properties.
MedLine Citation:
PMID:  7493053     Owner:  NLM     Status:  MEDLINE    
While conducting pharmacological investigations into oxygen carriers, it is important to study the in vitro and in vivo rheological behavior of blood cells in the presence of such preparations. With regard to the original nature of human hemoglobin bound to benzene tetracarboxylate substituted dextran (Dex-BTC-Hb), it seemed necessary to study its rheological effect in a simulated in vitro hemorrhagic shock compensated by a blood substitute. The viscosity of substitutes was determined as well as several rheological parameters after 0, 3 and 6 hours incubation periods of red blood cells with substitutes: viscosity of blood-substitute mixtures at different levels of plasma substitution erythrocyte aggregation of blood-substitute mixtures by determining the velocity of rouleau formation and the cohesion of rouleau network. This work yielded several observations: The viscosity of Dex-BTC-Hb was slightly higher than those of solutions of native Hb, Dex-BTC T10, Dextran 40 (Plasmacair, modified fluid gelatin (Plasmion and hydroxyethyl starch 200 (Elohes). The substitution of a blood volume with Dex-BTC-Hb, corresponding to a compensated 45% hemorrhagic shock, slightly increased the viscosity of hemodiluted blood as compared to other substitutes. In the presence of Dex-BTC-Hb, the aggregation of erythrocytes appears to be increased as compared to standard solutions. Yet, the effect was close to that of Plasmion or Elohes.
P Menu; M Donner; B Faivre; P Labrude; C Vigneron
Related Documents :
12498953 - The effect of pulsed ultrasound exposure on the oxygen dissociation curve of human eryt...
23557683 - Molecular characterization and distribution of haemoproteus minutus (haemosporida, haem...
3739583 - Evaluation of blood loss during suction termination of pregnancy: ketamine compared wit...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Artificial cells, blood substitutes, and immobilization biotechnology     Volume:  23     ISSN:  1073-1199     ISO Abbreviation:  Artif Cells Blood Substit Immobil Biotechnol     Publication Date:  1995  
Date Detail:
Created Date:  1996-01-11     Completed Date:  1996-01-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9431307     Medline TA:  Artif Cells Blood Substit Immobil Biotechnol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  319-30     Citation Subset:  IM    
Laboratoire d'Hématologie-Physiologie, Faculté de Pharmacie, Nancy, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Flow Velocity*
Blood Substitutes / pharmacology*
Dextrans / pharmacology*
Erythrocyte Aggregation / drug effects
Hemoglobins / pharmacology*
Plasma Substitutes / pharmacology
Stress, Mechanical
Reg. No./Substance:
0/Blood Substitutes; 0/Hemoglobins; 0/Plasma Substitutes; 0/hemoglobin-dextran 10-benzene-tetracarboxylate; 9004-54-0/Dextrans

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intramolecular cross-linking of oxy hemoglobin by bis sulfosuccinimidyl suberate and sebacate: gener...
Next Document:  A comparative study of the accurate measurement of endotoxin in liposome-encapsulated hemoglobin.